Healthcare & Life Sciences
Adaptive Phage Therapeutics
United Stateswww.aphage.com/
Adaptive Phage Therapeutics is a series b startup based in United States. 2 investors tracked.
Activeseries-b
series-b
Stage
2010
Founded
1
Investors
About Adaptive Phage Therapeutics
Adaptive Phage Therapeutics is a startup founded in 2010 based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Adaptive Phage Therapeutics (APT) is a clinical-stage company advancing a phage-based therapeutic approach for the treatment of multi-drug resistant bacterial infections.
Explore Adaptive Phage Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.
Other Startups in United States
Adaptive InsuranceseedAdaptive InsightsacquiredAdaptive Innovationsseries-aAdaptive Construction Solutionsseries-aAdaptive ComputerseedAdaptive Automation Technologiesseries-aAdaptive PulseAdaptive Real Estateseries-aAdaptive Securityseries-bAdaptive Surface Technologiesseries-c-plusAdapt-NAdaptxseries-b